Evidence map›Paper›PMID 32968720›Full record

ArticleNeuro-oncology advances

Long-term cognitive deficits in pediatric low-grade glioma (LGG) survivors reflect pretreatment conditions-report from the German LGG studies.

Thomas Traunwieser, Daniela Kandels, Franz Pauls, Torsten Pietsch, Monika Warmuth-Metz, Brigitte Bison, Juergen Krauss, Rolf-Dieter Kortmann, Beate Timmermann, Ulrich-Wilhelm Thomale and 6 more

Open access · goldAbstract read
In one paragraph

Article in Neuro-oncology advances. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Prospective analysis on possible changes of cognitive functions in children on follow-up for brain tumor.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 9 institutions in 1 country.

Thomas TraunwieserPaediatrics and Adolescent Medicine, Medical Faculty, University of Augsburg, Augsburg, Germany.ORCID 0000-0002-2228-031X
Daniela KandelsPaediatrics and Adolescent Medicine, Medical Faculty, University of Augsburg, Augsburg, Germany.
Franz PaulsDepartment of Clinical Psychology, Helmut Schmidt University, Hamburg, Germany.
Torsten PietschInstitute of Neuropathology, DGNN Brain Tumor Reference Center, University Bonn, Bonn, Germany.
Monika Warmuth-MetzInstitute of Diagnostic and Interventional Neuroradiology, University Hospital Wuerzburg, Wuerzburg, Germany.
Brigitte BisonInstitute of Diagnostic and Interventional Neuroradiology, University Hospital Wuerzburg, Wuerzburg, Germany.
Juergen KraussSection of Pediatric Neurosurgery, University Hospital Wuerzburg, Wuerzburg, Germany.
Rolf-Dieter KortmannDepartment of Radio-Oncology, University Leipzig, Leipzig, Germany.
Beate TimmermannDepartment of Particle Therapy, University Hospital Essen, West German Proton Therapy Centre Essen (WPE), West German Cancer Center (WTZ), German Cancer Consortium (DKTK), Essen, Germany.
Ulrich-Wilhelm ThomalePediatric Neurosurgery, Charité Universitaetsmedizin Berlin, Berlin, Germany.
Peggy LuettichHopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and Heidelberg University Hospital, Heidelberg, Germany.
Anne Neumann-HolbeckUniversity Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Tanja TischlerUniversity Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Pablo Hernáiz DrieverDepartment of Pediatric Oncology/Hematology, Charité-Universitaetsmedizin Berlin, Corporate member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Olaf WittHopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and Heidelberg University Hospital, Heidelberg, Germany.
Astrid K GnekowPaediatrics and Adolescent Medicine, Medical Faculty, University of Augsburg, Augsburg, Germany.ORCID 0000-0002-7356-6887
Universitätsklinikum Würzburg · DEUniversity of Augsburg · DEGerman Cancer Research Center · DEUniversität Hamburg · DECharité - Universitätsmedizin Berlin · DEDeutschen Konsortium für Translationale Krebsforschung · DEHelmut Schmidt University · DEHumboldt-Universität zu Berlin · DELife & Brain (Germany) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDisease and treatment contribute to cognitive late effects following pediatric low-grade glioma (LGG). We analyzed prospectively collected neuropsychological data of German pediatric LGG survivors and focused on the impact of hydrocephalus at diagnosis, neurofibromatosis type 1 (NF1) status, and extent of surgery.

methodsWe used the Neuropsychological Basic Diagnostic screening tool based on the Cattell-Horn-Carroll model for intelligence and the concept of cross-battery assessment at 2 and 5 years from diagnosis for 316 patients from the German pediatric LGG study and LGG registry (7.1 years median age; 45 NF1; cerebral hemispheres 16%, supratentorial midline 39%, infratentorial 45%). Hydrocephalus was classified radiologically in 137 non-NF1 patients with infratentorial tumors (95/137 complete/subtotal resection).

resultsPatients with NF1 versus non-NF1 exhibited inferior verbal short-term memory and visual processing (

conclusionsAll pediatric LGG survivors are at risk to experience long-term cognitive impairments in various domains. Even surgical only management of cerebellar LGG or no treatment at all, that is, biopsy only/radiological diagnosis did not protect cognitive function. Since pattern and extent of deficits are crucial to tailor rehabilitation, neuropsychological and quality of survival assessments should be mandatory in future LGG trials.

Indexed as

hydrocephalusneurofibromatosisneuropsychologypediatric low-grade gliomaresection

Identifiers

PMID32968720
PMCPMC7497816
OpenAlexW3047782867

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.